Further studies needed before using renin-angiotensin-aldosterone system blockade for atrial fibrillation prevention in hypertrophic cardiomyopathy.

Autor: Ramchand J; Department of Medicine, The University of Melbourne, Austin Health, Heidelberg, Victoria, Australia.; Department of Cardiology, Austin Health, Heidelberg, Victoria, Australia., Sampaio Rodrigues T; Department of Medicine, The University of Melbourne, Austin Health, Heidelberg, Victoria, Australia., Yudi MB; Department of Medicine, The University of Melbourne, Austin Health, Heidelberg, Victoria, Australia.; Department of Cardiology, Austin Health, Heidelberg, Victoria, Australia., Burrell LM; Department of Medicine, The University of Melbourne, Austin Health, Heidelberg, Victoria, Australia.; Department of Cardiology, Austin Health, Heidelberg, Victoria, Australia.
Jazyk: angličtina
Zdroj: Heart (British Cardiac Society) [Heart] 2018 Dec; Vol. 104 (23), pp. 1985.
DOI: 10.1136/heartjnl-2018-313929
Abstrakt: Competing Interests: Competing interests: None declared.
Databáze: MEDLINE